Yeast-expressed polio type 1 stablized virus-like particles with 3G10 Fab
收藏NIAID Data Ecosystem2026-05-10 收录
数据链接：
官方服务：
资源简介：
Yeast-expressed polio type 1 stablized virus-like particles with 3G10 Fab
应用场景：
创建时间：
2026-04-15
相关数据集
Table_1_Bacterial expression systems based on Tymovirus-like particles for the presentation of vaccine antigens.DOCX
Virus-like particles (VLPs) are virus-derived artificial nanostructures that resemble a native virus-stimulating immune system through highly repetitive surface structures. Improved safety profiles, f
NIAID Data Ecosystem100
Additional file 1 of Stability and integrity of self-assembled bovine parvovirus virus‑like particles (BPV‑VLPs) of VP2 and combination of VP1VP2 assisted by baculovirus-insect cell expression: a potential logistical platform for vaccine deployment
Additional file 1: Fig. S1. Virus particles (natural virus) and Virus-like particles (VLPs) have comparable structures, are easily recognized by the immune system, and deliver viral antigens in a mann
NIAID Data Ecosystem10
Poliovirus complexed with soluble, deglycosylated poliovirus receptor (Pvr) at 4 degrees C
Poliovirus complexed with soluble, deglycosylated poliovirus receptor (Pvr) at 4 degrees C
NIAID Data Ecosystem10
Data_Sheet_3_Characterization of surface-exposed structural loops as insertion sites for foreign antigen delivery in calicivirus-derived VLP platform.CSV
Chimeric virus-like particles (cVLPs) show great potential in improving public health as they are safe and effective vaccine candidates. The capsid protein of caliciviruses has been described previous
NIAID Data Ecosystem20
RNA Sequencing of dendritic cells treated with glycan-costumed virus-like particles
We engineered a glycan-costumed virus-like particle (VLP) vaccine that delivers programmable peptide antigens to induce tumor-specific cellular immunity in vivo. VLPs encapsulating TLR7 agonists were
NIAID Data Ecosystem10
